Your browser doesn't support javascript.
loading
Duplex-immunoassay of ovarian cancer biomarker CA125 and HE4 based carbon dot decorated dendritic mesoporous silica nanoparticles.
Wang, Zi-Xuan; Ding, Shou-Nian.
  • Wang ZX; Jiangsu Province Hi-Tech Key Laboratory for Bio-medical Research, School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China. snding@seu.edu.cn.
  • Ding SN; Jiangsu Province Hi-Tech Key Laboratory for Bio-medical Research, School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China. snding@seu.edu.cn.
Analyst ; 148(3): 683-689, 2023 Jan 31.
Article en En | MEDLINE | ID: mdl-36629898
Fluorescent lateral flow immunoassay (FLFIA) is widely used mainly because of its low cost and instant detection. Its limit of detection (LOD) is closely related to fluorescence signals, and the development of fluorescence signals with fine performance remains a challenge. In this work, dendritic mesoporous silica nanoparticles (DMSNs) were used as fine carriers due to their large pore size and stable performance. We successfully synthesized carbon dots (CDs) with a 560 nm maximum emission wavelength (CD560) by the hydrothermal method. A new type of fluorescence signal for FLFIA was observed by loading CD560 on DMSNs through the Si-O bond which is denoted as DMSNs@CD560. Applying DMSNs@CD560 to the FLFIA can eliminate the influence of interfacial background blue fluorescence thus improving its detection sensitivity. The formed DMSNs@CD560-FLFIA achieved high sensitivity detection of ovarian cancer biomarkers carbohydrate antigen 125 (CA125) and human epididymal protein 4 (HE4). The LOD of CA125 is 0.5 U mL-1 and the correlation coefficient R2 = 0.985, and the LOD of HE4 reaches 0.05 ng mL-1 and the correlation coefficient R2 = 0.981. The DMSNs@CD560-FLFIA is sensitive and efficient providing a new method for the early diagnosis of ovarian cancer.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Nanopartículas Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Nanopartículas Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Female / Humans Idioma: En Año: 2023 Tipo del documento: Article